Data for (Study ST001165)

(Analysis AN001926)

Values for each metabolite have been scaled by dividing by the mean across all factors

Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study

MetaboliteF1F2F3F4
1_CE (22:1) iSTD 0.9974 1.0075 0.9926 1.0026
1_Ceramide C17 iSTD 1.0328 0.9733 0.9935 1.0005
1_Cholesterol d7 iSTD 1.0423 0.9778 0.9937 0.9861
1_CUDA (pos) iSTD 0.9799 0.9986 1.0239 0.9976
1_DG (12:0/12:0/0:0) iSTD 1.0477 0.9864 0.9828 0.9831
1_DG (18:1/2:0/0:0) iSTD 1.0281 0.9865 0.9834 1.0020
1_iSTD iSTD SM (d18:1/17:0) iSTD 1.0098 0.9729 0.9917 1.0257
1_LPC (17:0) iSTD 1.0410 0.9715 0.9987 0.9887
1_LPE (17:1) iSTD 1.0285 0.9719 1.0030 0.9966
1_MG (17:0/0:0/0:0) iSTD 1.0236 0.9951 0.9687 1.0126
1_PC (25:0) iSTD 1.0342 0.9762 1.0069 0.9826
1_PE (17:0/17:0) iSTD 1.0484 0.9669 0.9730 1.0117
1_Sphingosine (d17:1) iSTD 1.0164 0.9823 0.9905 1.0108
1_TG (17:0/17:1/17:0) d5 iSTD 1.0342 0.9958 0.9556 1.0144
DG (38:5) 1.1140 0.9956 1.0139 0.8764
Gal-Gal-Cer(d18:1/16:0) or Lactosylceramide(d18:1/16:0) 0.7607 0.6846 0.6443 1.9104
LPC (14:0) 0.8587 0.9404 0.9828 1.2181
LPC (15:0) 0.8150 0.9546 0.9670 1.2634
LPC (16:0) 0.8236 0.8730 0.9736 1.3297
LPC (16:1) 0.8771 0.8182 0.9177 1.3871
LPC (18:1) 1.3518 0.7164 0.8219 1.1100
LPC (18:2) 1.0975 0.8513 0.9251 1.1261
LPC (20:3) 0.8276 0.8694 0.9727 1.3304
LPC (20:4) 0.8166 0.7225 1.0163 1.4446
LPC (20:5) 0.7739 0.8536 0.8530 1.5194
LPC (22:6) 0.6869 0.7044 0.8455 1.7632
PC (28:0) 0.6322 1.0524 0.8126 1.5028
PC (30:0) 0.6996 1.0096 0.8812 1.4096
PC (30:1) 0.6110 1.0621 0.8114 1.5155
PC (31:0) 0.7849 1.0563 0.9244 1.2344
PC (31:1) 0.7239 1.0857 0.8995 1.2908
PC (34:2) 0.7970 1.0253 0.9029 1.2749
PC (34:3) 0.7079 0.8827 0.9287 1.4807
PC (34:4) 0.5938 1.0519 0.7944 1.5598
PC (35:3) 0.7116 1.0840 0.9323 1.2721
PC (35:4) 0.6651 0.9542 0.9358 1.4450
PC (36:3) B 0.8982 0.9506 0.9083 1.2428
PC 36:4; 0.7073 1.0267 0.8760 1.3901
PC (36:4) A 0.6932 1.0101 0.9978 1.2988
PC (36:5) A 0.6624 1.0474 0.8321 1.4581
PC (36:5) B 0.6757 0.9727 0.8594 1.4922
PC (36:6) 0.6404 1.0170 0.8409 1.5016
PC (37:4) 0.7573 1.0058 0.8691 1.3678
PC 37:5; PC(19:1/18:4); 0.7510 1.0598 0.8698 1.3194
PC (37:6) 0.6420 0.9401 0.8770 1.5409
PC (38:5) A 0.7720 0.9814 0.8698 1.3767
PC (38:5) B 0.7725 1.0204 0.8425 1.3646
PC (38:6) A 0.7615 0.9839 0.8672 1.3874
PC (38:6) B 0.7272 0.9289 0.9802 1.3637
PC (38:6) C 0.8102 0.9684 0.8260 1.3954
PC (38:7) 0.6722 0.9956 0.8052 1.5270
PC (39:6) 0.7084 1.0339 0.8656 1.3921
PC 40:10; 0.7350 1.0399 0.8489 1.3762
PC (40:5) A 0.7591 1.0347 0.9619 1.2444
PC (40:6) A 0.7229 1.0602 0.8697 1.3473
PC (40:7) 0.8137 1.0153 0.8789 1.2921
PC (40:8) 0.7729 0.9768 0.8679 1.3824
PC 42:11; PC(20:5/22:6); 0.7206 0.9290 0.8374 1.5130
PC (p-34:0) or PC (o-34:1) 0.8859 0.9928 1.0820 1.0393
PC (p-36:4) or PC (o-36:5) 0.8146 1.0574 0.8901 1.2379
PC (p-38:5) or PC (o-38:6) 0.7274 0.9380 0.8982 1.4364
PC (p-42:3) or PC (o-42:4) 1.0150 1.0776 0.8911 1.0163
PE (34:2) 0.9021 0.9166 1.0350 1.1463
PE (38:6) 1.0199 0.8894 0.8494 1.2413
PE (p-36:2) or PE (o-36:3) 0.8260 1.0099 0.8541 1.3099
PE (p-36:4) or PE (o-36:5) 0.8782 1.0783 0.8519 1.1916
PE (p-38:4) or PE (o-38:5) 0.7529 1.0601 0.9335 1.2536
PE (p-38:5) or PE (o-38:6) 0.8685 1.0616 0.8199 1.2500
PE (p-40:5) or PE (o-40:6) 1.0120 1.0707 0.8991 1.0182
Plasmenyl-PC 36:4; 0.7648 0.9949 0.8852 1.3551
Plasmenyl-PC 37:5; 0.7522 0.9888 0.8581 1.4009
Plasmenyl-PC 38:6; 0.8514 1.0063 0.8412 1.3011
SM (d36:2) 1.6400 0.7939 0.7756 0.7905
SM (d36:3) 0.6942 1.0470 0.8933 1.3655
SM (d38:2) 2.0187 0.6466 0.6652 0.6695
TG (54:5) A 1.2929 0.8950 0.9648 0.8473
Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study

Factors:

F1ph treatment:High | DO treatment:High
F2ph treatment:High | DO treatment:Low
F3ph treatment:Low | DO treatment:High
F4ph treatment:Low | DO treatment:Low
  logo